Determination of glutamic acid decarboxylase 65 peptides presented by the type I diabetes-associated HLA-DQ8 class II molecule identifies an immunogenic peptide motif

Journal of Immunology

Volumn 163, Issue 11, 1999, Pages 6275-6282

  Herman, Ann E ^a   Tisch, Roland M ^a   Patel, Salil D ^a   Parry, Sarah L ^a   Olson, Jennifer ^a   Noble, Janelle A ^b,c   Cope, Andrew P ^a   Cox, Brett ^a   Congia, Mauro ^a   McDevitt, Hugh O ^a,d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OAKLAND   (United States)

^c ROCHE MOLECULAR SYSTEMS   (United States)

^d STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GLUTAMATE DECARBOXYLASE; HLA DQ ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; EPITOPE MAPPING; HUMAN; HUMAN CELL; HYBRIDOMA; IMMUNOGENICITY; INSULIN DEPENDENT DIABETES MELLITUS; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SURFACE CHARGE; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

ANIMALS; ANTIGEN PRESENTATION; DIABETES MELLITUS, TYPE 1; EPITOPE MAPPING; GENES, MHC CLASS II; GLUTAMATE DECARBOXYLASE; HLA-DQ ANTIGENS; HUMANS; ISOENZYMES; MICE; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS;

EID: 0033485917     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Castano, L., and G. S. Eisenbarth. 1990. Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu. Rev. Immunol. 8:647.
2. Nepom, G. T., and H. Erlich. 1991. MHC class-II molecules and auloimmunity. Annu. Rev. Immunol. 9:493.
3. Todd, J. A. 1997. Genetics of type 1 diabetes. Pathol. Biol. (Paris) 45:219.
4. Todd, J. A., H. Acha-Orbea, J. I. Bell, N. Chao, Z. Fronek, C. O. Jacob, M. McDermott, A. A. Sinha, L. Timmerman, L. Steinman, et al. 1988. A molecular basis for MHC class II-associated autoimmunity [published erratum appears in 1988, Science 241:888]. Science 240:1003.
5. Todd, J. A., J. I. Bell, and H. O. McDevitt. 1987. HLA-DQ β gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329: 599.
6. Jameson, S. C., K. A. Hogquist, and M. J. Bevan. 1995. Positive selection of thymocytes. Annu. Rev. Immunol. 13:93.
7. Kanagawa, O., B. A. Vaupel, G. Xu, E. R. Unanue, and J. D. Katz. 1998. Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC β-chain mutant. J. Immunol. 161:4489.
8. Rammensee, H. G., T. Friede, and S. Stevanoviic. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41:178.
9. Stern, L. J., J. H. Brown, T. S. Jardetzky, J. C. Gorga, R. G. Urban, J. L. Strominger, and D. C. Wiley. 1994 Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368: 215.
10. Kwok, W. W., M. E. Domeier, M. L. Johnson, G. T. Nepom, and D. M. Koelle. 1996. HLA-DQB1 codon 57 is critical for peptide binding and recognition. J. Exp. Med. 183:1253.
11. Wucherpfennig, K. W., and J. L. Strominger. 1995. Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune diseases. J. Exp. Med. 181:1597.
12. Chicz, R. M., W. S. Lane, R. A. Robinson, M. Trucco, J. L. Strominger, and J. C. Gorga. 1994. Self-peptides bound to the type I diabetes associated class II MHC molecules HLA-DQ1 and HLA-DQ8. Int. Immunol. 6:1639.
13. Godkin, A., T. Friede, M. Davenport, S. Stevanovic, A. Willis, D. Jewell, A. Hill, and H. G. Rammensee. 1997. Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2). Int. Immunol. 9:905.
14. Roep, B. O. 1996. T-cell responses to autoantigens in IDDM: the search for the Holy Grail. Diabetes 45:1147.
15. Lemmark, A. 1996. Glutamic acid decarboxylase: gene to antigen to disease. J. Intern. Med. 240:259.
16. Schloot, N. C., B. O. Roep, D. R. Wegmann, L. Yu, T. B. Wang, and G. S. Eisenbarth. 1997. T-cell reactivity to GAD65 peptide sequences shared with coxsackie vims protein in recent-onset IDDM, post-onset IDDM patients and control subjects. Diabetologia 40:332.
17. Hawa, M., R. Rowe, M. S. Lan, A. L. Notkins, P. Pozzilli, M. R. Christie, and R. D. Leslie. 1997. Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type I diabetes. Diabetes 46:1270.
18. Pietropaolo, M., M. Peakman, S. L. Pietropaolo, M. M. Zanone, T. P. Foley, Jr., D. J. Becker, and M. Trucco. 1998. Combined analysis of GAD65 and ICA512(IA-2) autoantibodies in organ and non-organ-specific autoimmune diseases confers high specificity for insulin-dependent diabetes mellitus. J. Autoimmun. 11:1.
19. Verge, C. F., R. Gianani, E. Kawasaki, L. Yu, M. Pietropaolo, R. A. Jackson, H. P. Chase, and G. S. Eisenbarth. 1996. Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45:926.
20. Cope, A. P., S. D. Patel, F. Hall, M. Congia, H. A. Hubers, G. F. Verheijden, A. M. Boots, R. Menon, M. Trucco, A. W. Rijnders, et al. 1999. T cell responses to a human cartilage autoantigen in the context of rheumatoid arthritis-associated and nonassociated HLA-DR4 alleles. Arthritis Rheum. 42:1497.
21. Taneja, V., and C. S. David. 1998. HLA transgenic mice as humanized mouse models of disease and immunity J. Clin. Invest. 101:921.
22. Wen, L., F. S. Wong, L. Burkly, M. Altieri, C. Mamalaki, D. Kioussis, R. A. Flavell, and R. S. Sherwin. 1998. Induction of insulitis by glutamic acid decarboxylase peptide-specific and HLA-DQ8-restricted CD4(+) T cells from human DQ transgenic mice [published erratum appears in 1998. J. Clin. Invest. 102:following 1463]. J. Clin. Invest. 102:947.
23. Liu, J., L. E. Purdy, S. Rabinovitch, A. M. Jevnikar, and J. F. Elliott. 1999. Major DQS-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice. Diabetes 48:469.
24. Hogan, B. 1986. Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
25. Patel, S. D., A. P. Cope, M. Congia, T. T. Chen, E. Kim, L. Fugger, D. Wherrett, and G. Sonderstrup-McDevitt. 1997. Identification of immunodominant T cell epitopes of human glutamic acid decarboxylase 65 by using HLA-DR(α1*0101,β1*0401) transgenic mice. Proc. Natl. Acad. Sci. USA 94:8082.
26. Chao, C. C., and H. O. McDevitt. 1997. Identification of immunogenic epitopes of GAD 65 presented by Ag7 in non-obese diabetic mice. Immunogenetics 46:29.
27. Noble, J. A., A. M. Valdes, M. Cook, W. Klitz, G. Thomson, and H. A. Erlich. 1996. The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. Am. J. Hum. Genet. 59:1134.
28. Zechel, M. A., J. F. Elliott, M. A. Atkinson, and B. Singh. 1998. Characterization of novel T-cell epitopes on 65 kDa and 67 kDa glutamic acid decarboxylase relevant in autoimmune responses in NOD mice. J. Autoimmun. 11:83.
29. Acha-Orbea, H., and H. O. McDevitt. 1987. The first external domain of the nonobese diabetic mouse class II I-A β chain is unique. Proc. Natl. Acad. Sci. USA 84:2435.
30. Lee, C., M. N. Liang, K. M. Tate, J. D. Rabinowitz, C. Beeson, P. P. Jones, and H, M. McConnell. 1998. Evidence that the autoimmune antigen myelin basic protein (MBP) Acl-9 binds towards one end of the major histocompatibility complex (MHC) cleft. J. Exp. Med. 187:1505.
31. Fremont, D. H., D. Monnaie, C. A. Nelson, W. A. Hendrickson, and E. R. Unanue. 1998. Crystal structure of I-Ak in complex with a dominant epitope of lysozyme. Immunity 8:305.
32. Carson, R. T., K. M. Vignali, D. L. Woodland, and D. A. Vignali. 1997. T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage. Immunity 7:387.
33. Carson, R. T., D. D. Desai, K. M. Vignali, and D. A. Vignali. 1999. Immunoregulation of Th cells by naturally processed peptide antagonists. J. Immunol. 162:1.
34. Ashton-Rickardt, P. G., and S. Tonegawa. 1994. A differential-avidity model for T-cell selection. Immunol. Today 15:362.
35. Nepom, B. S., G. T. Nepom, M. Coleman, and W. W. Kwok. 1996. Critical contribution of β chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules. Proc. Natl. Acad. Sci. USA 93:7202.
36. Boyton, R. J., T. Lohmann, M. Londei, H. Kalbacher, T. Halder, A. J. Frater, D. C. Douek, D. G. Leslie, R. A. Flavell, and D. M. Altmann. 1998. Glutamic acid decarboxylase T lymphocyte responses associated with susceptibility or resistance to type 1 diabetes: analysis in disease discordant human twins, non-obese diabetic mice and HLA-DQ transgenic mice. Int. Immunol. 10:1765.
37. Trotter, J. L., C. M. Pelfrey, A. L. Trotter, J. A. Selvidge, K. C. Gushleff, T. Mohanakumar, and H. F. McFarland. 1998. T cell recognition of myelin proteolipid protein and myelin proteolipid protein peptides in the peripheral blood of multiple sclerosis and control subjects. J. Neuroimmunol. 84:172.
38. Viner, N. J., C. A. Nelson, B. Deck, and E. R. Unanue. 1996. Complexes generated by the binding of free peptides to class II MHC molecules are antigenitically diverse compared with those generated by intracellular processing. J. Immunol. 156:2365.